DOI: 10.1128/AAC.00985-17
Article Information
PubMed
Published By
History
- Received May 14, 2017
- Returned for modification June 12, 2017
- Accepted September 9, 2017
- Published online November 22, 2017.
Copyright & Usage
Copyright © 2017 American Society for Microbiology.
All Rights Reserved
.
Article Versions
- Accepted Manuscript version (September 18, 2017).
- You are viewing the most recent version of this article.
Author Information
- Sivashangarie S. Sivanesana,
- Mohammad A. K. Azadb,
- Elena K. Schneidera,
- Maizbha U. Ahmeda,b,
- Jiayuan Huanga,b,
- Jiping Wanga,
- Jian Lib,
- Roger L. Nationa and
- Tony Velkova
- aDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia
- bMonash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Victoria, Australia
- Address correspondence to Tony Velkov, tony.velkov{at}unimelb.edu.au.
R.L.N. and T.V. are co-senior authors.
Citation Sivanesan SS, Azad MAK, Schneider EK, Ahmed MU, Huang J, Wang J, Li J, Nation RL, Velkov T. 2017. Gelofusine ameliorates colistin-induced nephrotoxicity. Antimicrob Agents Chemother 61:e00985-17. https://doi.org/10.1128/AAC.00985-17 .
